Aardvark Therapeutics Income Statement (2024-2026) | AARD

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & Cost
Interest income
Interest Income - Total (Quarter) 0.10M0.59M1.00M0.72M1.18M1.49M1.35M1.12M0.89M
Interest expenses
Interest Expenses (Quarter) 3.17M0.00M0.02M
Interest Income - Net (Quarter) 0.10M0.59M1.00M-2.46M1.17M1.47M1.35M1.12M0.89M
Operating Items
Research & Development (Quarter) 1.21M4.03M4.07M8.06M7.75M13.14M13.74M14.30M16.57M
Wages, Salaries and Other (Quarter) 0.45M1.07M1.20M1.54M2.06M2.70M3.05M4.19M3.71M
Selling, General & Administrative (Quarter) 0.86M2.03M1.03M1.39M2.71M2.70M3.97M4.41M5.90M
Other Operating Expenses (Quarter) 0.10M0.01M
Operating Expenses (Quarter) 2.17M6.07M5.09M9.45M10.47M15.85M17.70M18.70M22.46M
Operating Income (Quarter) -2.17M-6.07M-5.09M-9.45M-10.47M-15.85M-17.70M-18.70M-22.46M
EBIT (Quarter) -2.17M-6.07M-5.09M-9.45M-10.47M-15.85M-17.70M-18.70M-22.46M
Non-operating items
Non Operating Investment Income (Quarter) -0.11M0.03M-0.09M-0.05M-0.01M-0.01M0.04M-0.02M-0.01M
Interest & Investment Income (Quarter) 0.10M0.59M1.00M0.72M1.18M1.49M1.35M1.12M0.89M
Non Operating Income (Quarter) -0.01M0.62M0.91M0.67M1.16M1.48M1.39M1.11M0.88M
Net income details
EBT (Quarter) -2.07M-5.48M-4.09M-11.91M-9.30M-14.38M-16.35M-17.58M-21.57M
Profit After Tax (Quarter) -2.18M-5.45M-4.18M-8.78M-9.31M-14.37M-16.32M-17.60M-21.59M
Income from Continuing Operations (Quarter) -2.07M-5.48M-4.09M-11.91M-9.30M-14.38M-16.35M-17.58M-21.57M
Consolidated Net Income (Quarter) -2.07M-5.48M-4.09M-11.91M-9.30M-14.38M-16.35M-17.58M-21.57M
Income towards Parent Company (Quarter) -2.07M-5.48M-4.09M-11.91M-9.30M-14.38M-16.35M-17.58M-21.57M
Net Income towards Common Stockholders (Quarter) -2.07M-5.48M-4.09M-11.91M-9.30M-14.38M-16.35M-17.58M-21.57M
Additional items
EPS (Basic) (Quarter) -0.52-1.38-1.03-2.98-0.70-0.66-0.75-0.90-0.99
EPS (Diluted) (Quarter) -0.52-1.38-1.03-2.98-0.70-0.66-0.75-0.90-0.99
Shares Outstanding (Quarter) 3.97M3.97M3.99M4.00M13.19M21.69M21.71M19.62M21.82M
Shares Outstanding (Diluted) (Quarter) 3.97M3.97M3.99M4.00M13.19M21.69M21.71M19.62M21.82M
EBITDA (Quarter) -2.17M-6.07M-5.09M-9.45M-10.47M-15.85M-17.70M-18.70M-22.46M